Collagen Solutions PLC Director/PDMR Shareholding (4898K)
April 11 2018 - 2:01AM
UK Regulatory
TIDMCOS
RNS Number : 4898K
Collagen Solutions PLC
11 April 2018
Collagen Solutions Plc
(the "Company")
Director/PDMR Dealing
The Company announces that it was notified on 10 April that
David Evans, Chairman of the Company, has purchased 3,142,857
ordinary shares in the Company ("Ordinary Shares") at 2.75 pence
per Ordinary Share.
Following the transaction, David Evans' total beneficial holding
in the Company has increased to 42,537,411 Ordinary Shares
representing 13.11 per cent. of the issued ordinary share capital
of the Company.
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them.
1 Details of the person discharging managerial
responsibilities / person closely associated
--- -----------------------------------------------------------
a) Name David Evans
--- ------------------------- --------------------------------
2 Reason for the notification
--- -----------------------------------------------------------
a) Position/status Chairman
--- ------------------------- --------------------------------
b) Initial notification Initial
/Amendment
--- ------------------------- --------------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------------
a) Name Collagen Solutions plc
--- ------------------------- --------------------------------
b) LEI 213800IFY1CVGRGETL95
--- ------------------------- --------------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------------
a) Description of Ordinary shares of 1p each
the financial
instrument, type
of instrument ISIN: GB00B94T6Y14
Identification
code
--- ------------------------- --------------------------------
b) Nature of the Purchase of shares
transaction
--- ------------------------- --------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
----------------- ----------
2.75p per share 3,142,857
----------------- ----------
--- ------------------------- --------------------------------
d) Aggregated information
- Aggregated volume N/A - single transaction
- Price
--- ------------------------- --------------------------------
e) Date of the transaction 10 April 2018
--- ------------------------- --------------------------------
f) Place of the transaction London Stock Exchange
--- ------------------------- --------------------------------
About Collagen Solutions:
Collagen Solutions Plc is a global supplier, developer, and
manufacturer of medical grade collagen, tissues, and related
medical devices and components for use in regenerative medicine,
medical devices and in-vitro diagnostics and research. The Company
is also expanding its range of biomaterials-based finished medical
devices based on its internal and acquired intellectual property
for commercialisation with partners via licensing and distribution
arrangements, including ChondroMimetic, an osteochondral scaffold
for repairing cartilage defects in the knee. The Company's products
are used in a wide variety of applications including orthopaedics,
cardiovascular, dental, plastic surgery, wound healing, neurology
and urology.
For additional information on Collagen Solutions, please visit:
www.collagensolutions.com
Enquiries:
Collagen Solutions Plc Contact via Lisa Baderoon
Jamal Rushdy, Chief Executive
Officer
Hilary Spence, Chief Financial Tel: +44 (0) 7721 413
Officer 496
Lisa Baderoon, Head of Investor or lisa.baderoon@collagensolutions.com
Relations
Cenkos Securities plc (Nominated Tel: 0207 397 8900
Adviser and Broker)
Stephen Keys
Steve Cox
Callum Davidson
Walbrook PR Tel: 020 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001
Helen Cresswell
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHFKKDNABKDCQD
(END) Dow Jones Newswires
April 11, 2018 02:01 ET (06:01 GMT)
Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2024 to May 2024
Collagen Solutions (LSE:COS)
Historical Stock Chart
From May 2023 to May 2024